Literature DB >> 373914

Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm.

J S Macdonald, M E Lippman, P V Woolley, P P Petrucci, P S Schein.   

Abstract

A patient with a benign hepatic neoplasm developing after treatment with estrogenic hormones is described. After excision, the neoplastic tissue was analyzed for the presence of cytosol estrogen and progesterone binding proteins. The neoplasm was classified as focal nodular hyperplasia of the liver and was demonstrated to contain high-affinity cytosol estrogen and progesterone hormone receptors. The estrogen-binding affinity of the neoplasm was three times greater than that of normal liver. Further investigation of cytosol hormone receptors in estrogen associated hepatic neoplasms will be required to define the role of these binding proteins in the possible etiology of certain liver tumors.

Entities:  

Keywords:  Biology; Cancer; Case Studies; Diseases; Endocrine System; Estrogens; Hepatic Effects--etiology; Histology; Hormones; Neoplasms; Oral Contraceptives; Physiology; Research Methodology; Studies

Mesh:

Substances:

Year:  1978        PMID: 373914     DOI: 10.1007/bf00253113

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  13 in total

1.  The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture.

Authors:  M Lippman; G Bolan; K Huff
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

2.  Benign hepatocellular tumours.

Authors:  T I Sörensen; H Baden
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

3.  Oral contraceptives and liver tumours.

Authors:  J P O'Sullivan
Journal:  Proc R Soc Med       Date:  1976-05

4.  Predicting response to endocrine therapy in human breast cancer: a hypothesis.

Authors:  K B Horwitz; W L McGuire
Journal:  Science       Date:  1975-08-29       Impact factor: 47.728

Review 5.  Some aspects of the interaction between natural and synthetic female sex hormones and the liver.

Authors:  H Adlercreutz; R Tenhunen
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

6.  Progesterone in uterus and plasma. VI. Uterine progesterone receptors during the estrus cycle and implantation in the guinea pig.

Authors:  E Milgrom; M Atger; M Perrot; E E Baulieu
Journal:  Endocrinology       Date:  1972-04       Impact factor: 4.736

7.  Progesterone and glucocorticoid interactions with receptor in breast cancer cells in long-term tissue culture.

Authors:  M Lippman; K Huff; G Bolan
Journal:  Ann N Y Acad Sci       Date:  1977-03-11       Impact factor: 5.691

8.  Letter: Oral contraceptives and malignant hepatoma.

Authors:  A B Glassberg; E H Rosenbaum
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

9.  Liver-cell adenomas associated with use of oral contraceptives.

Authors:  H A Edmondson; B Henderson; B Benton
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

10.  A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay.

Authors:  M Lippman; K Huff
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

View more
  7 in total

1.  Does human liver contain estrogen receptors? A comparative study of estrogen binding in human and rodent liver.

Authors:  H Bojar; J Schütte; W Staib; C Broelsch
Journal:  Klin Wochenschr       Date:  1982-04-15

2.  Estrogen receptors in hepatocellular carcinoma: is endocrine therapy for hepatocellular carcinoma likely to be effective?

Authors:  K Kohigashi; Y Fukuda; H Imura
Journal:  Gastroenterol Jpn       Date:  1987-06

3.  Steroid receptor status of focal-nodular hyperplasia of the human liver.

Authors:  H Bojar; D Petzinna; C Brölsch; W Staib
Journal:  Klin Wochenschr       Date:  1984-05-15

Review 4.  Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.

Authors:  C J Oon; M A Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.

Authors:  F Farinati; N De Maria; A Fornasiero; M Salvagnini; S Fagiuoli; M Chiaramonte; R Naccarato
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 6.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

7.  Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.

Authors:  M J Iqbal; M L Wilkinson; P J Johnson; R Williams
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.